Patient-reported outcomes (PROs) may help patients and clinicians in selecting disease-modifying therapies (DMTs) for multiple sclerosis (MS).
A snapshot on patient-reported outcome measures of people with multiple sclerosis on first-line therapies in a real world setting
Signoriello, E;Bisecco, A;Lus, G;Bonavita, S
2020
Abstract
Patient-reported outcomes (PROs) may help patients and clinicians in selecting disease-modifying therapies (DMTs) for multiple sclerosis (MS).File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
